TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07862595: A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Analgesic Effects and Safety of MK-6916 for Acute Pain Following Bunionectomy

Sponsor: Merck Sharp & Dohme LLC · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 380 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07862595 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07862595 Rescue Dossier →